<DOC>
	<DOCNO>NCT02874560</DOCNO>
	<brief_summary>In population patient suffer schizophrenia treat episode clinical destabilization follow period twelve month , main objective evaluate proportion patient achieve functional remission relationship clinical remission .</brief_summary>
	<brief_title>Evaluation Functional Remission Occurrence Predictive Factors Schizophrenia</brief_title>
	<detailed_description>Prospective , national , noninterventional study . One year follow three evaluation date ( D0 , D180 D360 ) . The participation subject study way impact regular care subject benefit otherwise entitle . All treatment decision make discretion participate physician , accordance clinical practice approve local prescribe information . Only data available clinical practice collect . Evaluation method : patient history clinical examination , clinical global impression ( CGI ) : Improvement CGI , social performance evaluation [ functional remission general schizophrenia ( FROGS scale ) ] , clinical remission evaluation : 8 item Positive negative syndrome ( PANSS ) Scale , psychosocial remission evaluation ( PSP scale ) , current insight evaluation : insight scale psychosis , subjective well neuroleptic treatment ( SWN scale ) , health condition [ Euro quality life - 5 Dimensions ( EQ-5D ) ] Í¾ Judgment Criteria : functional remission define overall score great equal ( &gt; = ) 57 FROGS scale , functional response define improvement &gt; = 7 point FROGS scale . Safety evaluation : tolerance analysis perform , adverse event ( AE ) serious adverse event ( SAE ) J &amp; J product collect transmit accord J &amp; J timelines/process .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients must male female adult patient age 18 37 year diagnosis schizophrenia accord diagnostic statistical manual mental disorder ( DSMIV ) criterion Treated schizophrenia Having read understood sign informed consent ( patient legal guardianship , legal guardian inform physician ) Patients must initiate longacting injectable antipsychotic treatment le 2 month previous treatment Patients must monitor treatment team hospital , medical psychiatric centre clinic least 6 month must likely follow team next year Resistant schizophrenia ( response receive two successive antipsychotic treatment effective dose , least fourweek period ) Drug alcohol dependence abuse ( nicotine caffeine abuse ) diagnose accord DSMIV month precede study inclusion process accord investigator could compromise participation study History neuroleptic malignant syndrome Inability comply requirement study ( e.g. , intellectual deficiency , inability unwillingness answer questionnaire ) accord investigator 's opinion Patients trusteeship patient receive psychiatric care without consent ( except patient care program ) Participation another study within 30 day prior study inclusion period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CNS</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Functional remission</keyword>
	<keyword>Observational study</keyword>
	<keyword>FROGS</keyword>
	<keyword>PSP</keyword>
	<keyword>Functioning</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>